I am comparing three suppliers on documentation rather than on price.
I would like help reading this properly rather than being told what conclusion to reach.
I have the full report including the method section, so I can quote specifics if that helps.
What would I need in addition before this supported a decision?
This is the tag where the site is least able to help and most obliged to say so plainly.
Most agents discussed on this site are prescription-only medicines where they are licensed at all, which places personal importation under medicines regulation rather than under drug-control law in most jurisdictions.
The underlying point is that the authority that matters is the national medicines regulator plus the customs authority, and both usually publish their position in plain language on their own websites.
Research-use-only labelling is a commercial convention originating in laboratory supply and carries no regulatory status for an individual importer.
Nothing here is medical advice, and research-use compounds are not approved for human use in any jurisdiction.
Research-use labelling is a seller's statement, not a legal category for you.
Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.
Browse results"For research use only" is a statement by the seller about intended use, and it binds nobody.
If the amount at stake is material, this is a question for a lawyer in your jurisdiction rather than for a forum in any jurisdiction.
A research-use-only label is a supplier's statement about intended use. It has no status in customs classification and does not create an exemption for the importer.
National medicines regulators and customs authorities publish their positions directly, and those are the primary sources for any specific question.
Onward supply is a materially different legal act and should not be assumed to follow the same rule as personal importation.
Prior successful deliveries tell you about enforcement, not about legality.
edited 3 Dec 2024 by ines_brandt — updated for the 2026 guidance change
Selling on is a different legal act from importing for yourself, in essentially every jurisdiction.
Some jurisdictions provide a limited personal-importation allowance for medicines, usually bounded by quantity, by a supply period and by a requirement that the substance is for the importer's own use. Others provide none.
It helps to be literal here: onward supply — including at cost, including to friends — is treated separately and much more seriously in most regimes than importation for personal use.
The caveat is the whole answer: nothing here is legal advice and the rule that applies to you is local.
Personal importation and onward supply are different acts under different rules.
The honest answer is that personal importation of a prescription-only medicine is restricted in most jurisdictions regardless of intended use.
Three broad categories cover most cases: controlled or scheduled substances, prescription-only medicines, and unclassified chemicals. The rules, penalties and enforcement posture differ sharply between them.
Personal-importation allowances for medicines exist in some jurisdictions with quantity and supply-period limits, and are absent in others.
Absence of enforcement is not permission, and prior deliveries prove nothing about the rule.
If the stakes are material, ask a lawyer where you live rather than a forum anywhere.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.